News
Cencora Inc. closed 3.50% below its 52-week high of $296.65, which the company reached on April 4th.
Shares of Cencora Inc. COR shed 1.95% to $281.16 Monday, on what proved to be an all-around grim trading session for the ...
6don MSN
We recently published a list of Jim Cramer is Bullish on These 10 Stocks. In this article, we are going to take a look at ...
13d
Zacks Investment Research on MSNHere's Why You Should Add Cencora Stock to Your Portfolio NowCencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.
Cencora COR +0.79% Get Free Report has outperformed the market over the past 10 years by 9.42% on an annualized basis ...
Insider Monkey on MSN22d
Jim Cramer on Cencora (COR): “Smart Moves in the Drug Middleman Game!”We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other stocks that Jim ...
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Growth stocks are ...
Chesterbrook, PA-based Cencora is one of the world’s largest pharmaceutical services companies, which focuses on providing drug distribution and related services to reduce health care costs and ...
Citi analyst Daniel Grosslight maintained a Buy rating on Cencora (COR – Research Report) today and set a price target of $330.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results